B-F9 KO mice_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Please input keywords

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

B-F9 KO mice

Strain Name	C57BL/6-F9^tm1Bcgen/Bcgen	Common Name	B-F9 KO mice
Background	C57BL/6	Catalog number	110170
Related Genes	F9；FIX（coagulation factor IX）

Project background

F9, also known as F9 p22 and FIX (coagulationfactor IX), is also located on the X chromosome like F8. It encodes a vitamin K-dependent serine protease (factor IX), which plays a key role in the intrinsic coagulation pathway. The zymogen is activated by XIa factor to obtain factor IXa, and then the inactive factor X is activated to factor Xa by the participation of factor VIIIa, calcium ions, and membrane phospholipids, and then the coagulation reaction continues. Deletion of the F9 gene leads to factor IX deficiency, which triggers coagulopathy and is hemophilia B with X-chromosome recessive inheritance, and it can be said that the F9 gene is of extraordinary significance for the study of hemophilia B.

Model validation and analysis

from clipboard

The experimental animals were randomly divided into groups and given NS (normal saline) or 3 mg/kg NovoSeven by tail vein injection, 30 minutes after injection of the drug, blood was collected from the abdominal aorta to detect the blood coagulation index: activated partial thromboplastin time APTT, Fibrinogen FIB.

The results showed that APTT values in B-F9 KO mice (male) were much higher than those in WT mice (male), and APTT returned to normal values after injection of ovoSeven (recombinant human coagulation factor VIIa). And there was no significant difference in FIB values between B-F9 KO mice and WT mice. The results showed that B-F9 KO mice can be used as a powerful tool for the validation of anticoagulant efficacy.